• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCAMP4 Therapeutics
    Picture of CAMP4 Therapeutics logo

    CAMP — CAMP4 Therapeutics Share News

    $3.300.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      $207.09m
    • Enterprise Value
      $120.69m
    • Revenue
      $3.50m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CAMP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CAMP Dividends
    • U.S. RESEARCH ROUNDUP-Autozone, Cognex, Royal Gold

      15/09/2025 09:12
    • U.S. RESEARCH ROUNDUP-Chewy, Phillips 66, Vimeo

      11/09/2025 08:57
    • Brief: CAMP4 Reports First Quarter 2025 Financial Results And Corporate Highlights

      13/05/2025 21:39
    • Brief: Camp4 Provides Corporate Updates And Highlights Key Upcoming Milestones

      07/01/2025 21:38
    • Brief: Camp4 Reports Third Quarter 2024 Financial Results

      21/11/2024 21:08
    • U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren

      05/11/2024 07:04
    • Brief: Amir Nashat reports 13.5% stake in CAMP4 Therapeutics

      22/10/2024 23:01
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.